# DARUNAVIR
> **ANDA207189** · Abbreviated New Drug Application (Generic) · Sponsor: CIPLA LTD · Approved 2017-03-16
## Drug
- **FDA Application Number:** ANDA207189
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** DARUNAVIR
- **Generic name:** Darunavir
- **Active ingredients:** DARUNAVIR
- **Dosage form:** TABLET
- **Route:** ORAL
- **Marketing status:** None (Tentative Approval)
- **Sponsor:** CIPLA LTD
- **First approval:** 2017-03-16
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=207189)
---
*MORVS · CC0 1.0*